Lancet 394:131138 Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB et al (2018) Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Wegovy Semaglutide Injected once weekly using a prefilled pen
If you're uncertain about your dosing, contact your GP surgery or diabetes specialist nurse before taking your injection
Supporting mul
Weight Loss Management at Soul Glow Medspa Getting started on your weight loss journey is one of the best decisions you can make for your health and wellness
The change in BMI, body weight and HbA1c did not differ between adults receiving multiple daily insulin injections and those using an insulin pump